Management of Methylprednisolone Reaction After IM Injection

Immediate Assessment and Stabilization

The American College of Oncology recommends stopping any further administration immediately, assessing for anaphylaxis versus hypersensitivity reaction, and administering intramuscular epinephrine 0.2-0.5 mg if anaphylaxis criteria are met, while maintaining IV access and monitoring vital signs 1, 2
Anaphylaxis indicators include sudden onset with rapid symptom intensification, hypotension, respiratory compromise, angioedema of tongue/airway, and involvement of 2+ organ systems, according to the American Journal of Hematology 4
Non-anaphylactic hypersensitivity indicators include mild urticaria without systemic symptoms, isolated flushing or mild chest tightness, as stated by the Annals of Oncology 1, 4

For anaphylaxis, the American College of Oncology recommends administering epinephrine 0.2-0.5 mg IM into lateral thigh immediately, and repeating every 5-15 minutes if no improvement, with fluid resuscitation and adjunctive medications as needed 1, 2, 3
The American Journal of Hematology suggests that for mild-moderate hypersensitivity, stopping any further methylprednisolone administration, maintaining IV access with normal saline, and monitoring vital signs for 15+ minutes is recommended 4, 6
Symptom-directed treatment, including second-generation antihistamines and hydrocortisone, may be necessary for mild-moderate hypersensitivity reactions, as stated by the American Journal of Hematology 4

The Annals of Oncology recommends monitoring vital signs continuously until complete symptom resolution, and observing for at least 6 hours after severe reactions or multiple epinephrine doses 1, 2, 3
Consider 24-hour observation for severe reactions due to risk of biphasic anaphylaxis, which occurs in up to 20% of cases, according to the American College of Oncology 1, 2, 3

The American College of Oncology warns against delaying epinephrine while waiting for antihistamines or corticosteroids to work, as this increases mortality and biphasic reaction risk 2, 5
Confusing vasovagal reactions with anaphylaxis can lead to inappropriate treatment, as vasovagal presents with bradycardia and pallor without cutaneous manifestations, while anaphylaxis typically causes tachycardia and urticaria, according to the American College of Oncology 2

The Annals of Oncology recommends documenting reaction severity, timing, symptoms, and interventions, and referring to an allergist for formal evaluation if true anaphylaxis occurred 2, 3
Educating the patient to avoid methylprednisolone in the future and carry an epinephrine auto-injector if anaphylaxis occurred is crucial, as stated by the American College of Oncology 2